NFE2L2 and psoriasis: In our previous work, [11,13], we observed increased expression of Keap1, which is a cytosolic inhibitor of another transcription factor—Nrf2—in granulocytes and lymphocytes of patients with psoriasis, which may support the degradation of IκB [53].